KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Finished Goods (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Finished Goods data on record, last reported at $1.0 billion in Q3 2025.

  • For Q3 2025, Finished Goods rose 37.8% year-over-year to $1.0 billion; the TTM value through Sep 2025 reached $1.0 billion, up 37.8%, while the annual FY2024 figure was $717.6 million, 18.42% up from the prior year.
  • Finished Goods reached $1.0 billion in Q3 2025 per ISRG's latest filing, up from $910.8 million in the prior quarter.
  • Across five years, Finished Goods topped out at $1.0 billion in Q3 2025 and bottomed at $276.1 million in Q4 2021.
  • Average Finished Goods over 5 years is $534.6 million, with a median of $470.0 million recorded in 2023.
  • Peak YoY movement for Finished Goods: decreased 20.41% in 2021, then surged 72.95% in 2023.
  • A 5-year view of Finished Goods shows it stood at $276.1 million in 2021, then grew by 26.91% to $350.4 million in 2022, then surged by 72.95% to $606.0 million in 2023, then increased by 18.42% to $717.6 million in 2024, then soared by 42.91% to $1.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $1.0 billion in Q3 2025, $910.8 million in Q2 2025, and $773.7 million in Q1 2025.